Coatesville, PA, United States of America

Peter R Seoane

This inventor holds 3 USPTO granted patents. Top assignees: Sterling Winthrop Inc., Eastman-Kodak Company. Active years: 1992-1996.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Peter R Seoane. Retrieved from https://idiyas.com/inventor/peter-r-seoane

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 5.1

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 1992-1996

Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Peter R. Seoane

Introduction

Peter R. Seoane is a notable inventor based in Coatesville, PA (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of bradykinin antagonists. With a total of 3 patents to his name, Seoane's work has had a meaningful impact on medical science.

Latest Patents

Seoane's latest patents focus on nonpeptide bradykinin antagonists. These patents disclose nonpeptides that exhibit bradykinin antagonist activity, specifically in the formulas (I) and (II). Additionally, they cover pharmaceutical compositions containing these compounds and methods for treating various diseased or pathological conditions using these compositions.

Career Highlights

Throughout his career, Peter R. Seoane has worked with prominent companies such as Sterling Winthrop Inc. and Eastman Kodak Company. His experience in these organizations has contributed to his expertise in pharmaceutical innovations.

Collaborations

Seoane has collaborated with notable coworkers, including David M. Faunce and Joseph M. Salvino. These partnerships have likely enriched his research and development efforts.

Conclusion

Peter R. Seoane's contributions to the field of pharmaceuticals, particularly through his patents on bradykinin antagonists, highlight his innovative spirit and dedication to advancing medical science. His work continues to influence the industry and improve treatment options for various conditions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…